Home » PRDT ANNOUNCES SIGNING OF LICENSE AGREEMENT
PRDT ANNOUNCES SIGNING OF LICENSE AGREEMENT
May 19, 2006
Pathogen Removal and Diagnostic Technologies Inc. (PRDT), a joint venture between
ProMetic Life Sciences Inc. (TSX:PLI) and the American Red Cross, today announced
that it has signed a definitive license agreement with MacoPharma.